6.7.2010 EN Official Journal of the European Union L 170/35
COMMISSION DECISION
of 18 June 2010
on the allocation of quantities of controlled substances other than hydrochlorofluorocarbons allowed for essential or critical laboratory and analytical uses in the Union in 2010 under Regulation (EC) No 1005/2009 of the European Parliament and of the Council on substances that deplete the ozone layer
(notified under document C(2010) 3850)
(Only the Dutch, English, Estonian, French, German, Italian and Spanish texts are authentic)
(2010/375/EU)
THE EUROPEAN COMMISSION
,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1005/2009 of the European Parliament and of the Council of 16 September 2009 on substances that deplete the ozone layer (1), and in particular Article 10(2) thereof,
Whereas:
(1) The Union has already phased out the production and consumption of chlorofluorocarbons, other fully halogenated chlorofluorocarbons, halons, carbon tetrachloride, 1,1,1-trichloroethane, hydrobromofluorocarbons and bromochloromethane for most uses. The Commission is required to determine essential laboratory and analytical uses for these controlled substances, the quantities that may be used and the companies that may use them.
(2) Decision XIX/18 of the Parties to the Montreal Protocol authorises the production and consumption necessary to satisfy essential laboratory and analytical uses of controlled substances listed in Annexes A, B and C (Group II and III substances) of the Montreal Protocol as listed in Annex IV to the report of the Seventh Meeting of the Parties, subject to the conditions set out in Annex II to the report of the Sixth Meeting of the Parties, as well as Decisions VI/9, VII/11, XI/15 XV/5, XVI/16 and XXI/16 of the Parties to the Montreal Protocol.
(3) Decision XVII/10 of the Parties to the Montreal Protocol authorises the production and consumption of methyl bromide, listed in Annex E of the Montreal Protocol, necessary to satisfy laboratory and analytical critical uses of methyl bromide.
(4) Under the Montreal Protocol global laboratory and analytical-use exemption is subject to periodic review and has last been extended by Decision XXI/6 until 31 December 2014.
(5) Decision VI/25 specifies that a use can only be considered as essential if there are no available technically and economically feasible alternatives or substitutes that are acceptable from the standpoint of environment and health. An Annex listing those uses for which the Parties of the Montreal Protocol consider alternatives to be available should be established. This Annex should also contain the positive list of permitted essential uses of methyl bromide, as agreed by the Parties in Decision XVIII/15.
(6) The Commission has published a notice to undertakings intending to import or export controlled substances that deplete the ozone layer to or from the European Union in 2010 and undertakings intending to request for 2010 a quota for these substances intended for laboratory and analytical uses (2) and has received declarations on intended essential laboratory and analytical uses of controlled substances for 2009.
(7) The measures provided for in this Decision are in accordance with the opinion of the Management Committee established by Article 25(1) of Regulation (EC) No 1005/2009,
The production and import of controlled substances other than hydrochlorofluorocarbons may be permitted for any essential laboratory and analytical use specified in Annex I.
The quantity of controlled substances other than hydrochlorofluorocarbons subject to Regulation (EC) No 1005/2009 which may be produced or imported for essential laboratory and analytical uses in the Union in 2010 shall be 63 843,371 ODP kilograms.
The allocation of essential laboratory and analytical use quotas for controlled substances other than hydrochlorofluorocarbons for the year 2010 shall be to the undertakings indicated in Annex II. The maximum quantities that may be produced or imported in 2010 for laboratory and analytical uses allocated to these undertakings shall be set out in Annex III.
This Decision shall apply from 1 January 2010 and shall expire on 31 December 2010.
This Decision is addressed to the following undertakings:
Acros Organics BVBA
Janssen Pharmaceuticalaan 3a
2440 Geel
BELGIUM
Estonian Environmental Research Centre
Marja 4D
10617 Tallinn
ESTONIA
Honeywell Specialty Chemicals GmbH
Wunstorfer Strasse 40
Postfach 100262
30918 Seelze
GERMANY
LGC Standards GmbH
Mercatorstr. 51
46485 Wesel
GERMANY
Ministry of Defence
Defence Fuel Lubricants and Chemicals
PO Box 10.000
1780 CA Den Helder
NETHERLANDS
Sicor SPA
Via Terazzano 77
20017 Rho (MI)
ITALY
Sigma Aldrich Company Ltd
The Old Brickyard, New Road
Gillingham SP8 4XT
UNITED KINGDOM
Sigma Aldrich Logistik GmbH
Riedstrasse 2
89555 Steinheim
GERMANY
VWR International SAS
201 rue Carnot
94126 Fontenay-sous-Bois
FRANCE
Airbus SAS
Route de Bayonne 316
31300 Toulouse
FRANCE
Harp International Ltd
Gellihirion Industrial Estate, Rhondda, Cynon Taff,
Pontypridd CF37 5SX
UNITED KINGDOM
Ineos Fluor Ltd
PO Box 13, The Heath
Runcorn Cheshire WA7 4QF
UNITED KINGDOM
Merck KGaA
Frankfurter Strasse 250
64271 Darmstadt
GERMANY
Panreac Quimica SA
Pol. Ind. Pla de la Bruguera, C/Garraf 2
08211 Castellar del Vallès-Barcelona
SPAIN
Sigma Aldrich Chimie SARL
80, rue de Luzais
L’Isle d’Abeau Chesnes
38297 St Quentin Fallavier
FRANCE
Sigma Aldrich Laborchemikalien GmbH
Wunstorfer Strasse 40
Postfach 100262
30918 Seelze
GERMANY
Tazzetti Fluids SRL
Corso Europa n. 600/a
Volpiano (TO)
ITALY